logo
  Join        Login             Stock Quote

Hospira Convenes Its 2012 Annual Meeting of Shareholders

Wednesday, May 9, 2012 1:23 PM


LAKE FOREST, Ill., May 9, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today held its 2012 Annual Meeting of Shareholders in Arlington, Va. 

The agenda included votes on five items. During the annual meeting, shareholders:

  • elected the following directors: Barbara L. Bowles, Roger W. Hale and John C. Staley, all Class II directors whose terms expire in 2015; and William G. Dempsey, a Class III director whose term expires in 2013;
  • approved two amendments to Hospira's restated certificate of incorporation to permit shareholders to call special meetings in accordance with the company's bylaws and to phase out the classification of the board over a three-year period;
  • approved, by means of a shareholder advisory vote, the compensation of Hospira's named executive officers ("say on pay") as disclosed in the company's 2012 proxy statement; and
  • ratified the appointment of Deloitte & Touche LLP as Hospira's auditors for 2012.

A full description of the above matters is included in Hospira's proxy statement related to the meeting. The proxy statement and annual report is available on Hospira's website at www.hospirainvestor.com.

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.

SOURCE Hospira, Inc.

(Source: PR Newswire )
(Source: Quotemedia)

Advertisement
Advertisement



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.